These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 2031261)
21. Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow. Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP Transplantation; 1997 Feb; 63(3):359-64. PubMed ID: 9039923 [TBL] [Abstract][Full Text] [Related]
22. Prolonged adult skin allograft survival as a result of cotransplantation with neonatal tissue. The requirement for antigen sharing between graft and cotransplant. Markees TG; De Fazio SR; Gozzo JJ Transplantation; 1992 Dec; 54(6):955-8. PubMed ID: 1465789 [TBL] [Abstract][Full Text] [Related]
23. Requirement for early donor cell chimerism during prolonged survival of murine skin allografts. Masli S; De Fazio SR; Gozzo JJ Transplantation; 2000 Apr; 69(8):1667-75. PubMed ID: 10836379 [TBL] [Abstract][Full Text] [Related]
24. Induction of prolonged tolerance to third-party skin grafts following fully allogeneic bone marrow transplantation in mice. Levite M; Reisner Y Transplantation; 1993 Mar; 55(3):633-8. PubMed ID: 8456484 [TBL] [Abstract][Full Text] [Related]
25. Prolongation of skin allograft survival after neonatal injection of donor bone marrow and epidermal cells. Petit F; Minns AB; Nazzal JA; Hettiaratchy SP; Lantieri LA; Randolph MA; Lee WP Plast Reconstr Surg; 2004 Jan; 113(1):270-6. PubMed ID: 14707646 [TBL] [Abstract][Full Text] [Related]
26. Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen. Nakafusa Y; Goss JA; Mohanakumar T; Flye MW Transplantation; 1993 Apr; 55(4):877-82. PubMed ID: 8475563 [TBL] [Abstract][Full Text] [Related]
27. Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts. Li H; Inverardi L; Molano RD; Pileggi A; Ricordi C Transplantation; 2003 Apr; 75(7):966-70. PubMed ID: 12698081 [TBL] [Abstract][Full Text] [Related]
28. The effect of antilymphocyte serum, fractionated donor bone marrow, and cyclosporine on renal allograft survival in mongrel dogs. Hartner WC; Markees TG; De Fazio SR; Khouri W; Maki T; Monaco AP; Gozzo JJ Transplantation; 1991 Nov; 52(5):784-9. PubMed ID: 1835194 [TBL] [Abstract][Full Text] [Related]
29. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells. Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518 [TBL] [Abstract][Full Text] [Related]
30. Effect of monoclonal anti-CD4 and anti-CD8 on skin allograft survival in mice treated with donor bone marrow cells. De Fazio SR; Masli S; Gozzo JJ Transplantation; 1996 Jan; 61(1):104-10. PubMed ID: 8560547 [TBL] [Abstract][Full Text] [Related]
31. The effect of injection of donor bone marrow on the frequency of donor-reactive CTL in antilymphocyte serum-treated, grafted mice. Wood ML; Orosz CG; Gottschalk R; Monaco AP Transplantation; 1992 Oct; 54(4):665-71. PubMed ID: 1412758 [TBL] [Abstract][Full Text] [Related]
32. Sex-associated differences in the survival of skin grafts in rats. Enhancement of cyclosporine immunosuppression in male compared with female recipients. Enosawa S; Hirasawa K Transplantation; 1989 Jun; 47(6):933-7. PubMed ID: 2660352 [TBL] [Abstract][Full Text] [Related]
33. Suppressor cells in specific unresponsiveness to skin allografts in thymectomized, ALS-treated, marrow-injected mice. Wood ML; Gottschalk R; Monaco AP Transplantation; 1979 Nov; 28(5):387-8. PubMed ID: 160636 [TBL] [Abstract][Full Text] [Related]
34. The induction of skin xenograft tolerance in rat-to-mouse combination could be affected by DFR mediating cells and antibodies against rat bone marrow cells as well as NK cells in the cyclophosphamide-induced tolerance system. Nishimura Y; Eto M; Maeda T; Hiromatsu K; Nomoto K; Kong YY; Nomoto K Immunobiology; 1995 Aug; 193(5):420-38. PubMed ID: 8522358 [TBL] [Abstract][Full Text] [Related]
35. Active role of chimerism in transplantation tolerance induced by antilymphocyte serum, sirolimus, and bone-marrow-cell infusion. Kanamoto A; Monaco AP; Maki T Transplantation; 2004 Sep; 78(6):825-30. PubMed ID: 15385800 [TBL] [Abstract][Full Text] [Related]
36. Evidence that cyclosporine does not inhibit allograft rejection by IL-2-treated sensitized splenocytes. Kemeny MM; Stephens DA Transplantation; 1987 Apr; 43(4):560-3. PubMed ID: 3554645 [TBL] [Abstract][Full Text] [Related]
37. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens. Shimomura K; Hardy MA; Oluwole SF Transplantation; 1995 Oct; 60(8):806-11. PubMed ID: 7482739 [TBL] [Abstract][Full Text] [Related]
38. The effect of timing of multiple donor-specific or nonspecific blood transfusions on skin allograft survival in ALS-treated mice. Wood ML; Gottschalk R; Monaco AP Transplantation; 1983 Oct; 36(4):388-91. PubMed ID: 6353706 [TBL] [Abstract][Full Text] [Related]
39. Immune capacity of mice tolerating a weakly incompatible skin allograft. I. Tolerance induction by neonatal skin graft in adult recipients or by neonatal inoculation of adult cells. Viklický V; Poláckovä M; Wabik B Folia Biol (Praha); 1975; 21(4):209-18. PubMed ID: 1102343 [TBL] [Abstract][Full Text] [Related]
40. Long-term survival and strain-specific tolerance induction in rat-to-mouse neonatal islet xenografts. Serie JR; Pringle JA; Cooper HN; Roth CM; Hegre OD Transplantation; 1993 Nov; 56(5):1166-70. PubMed ID: 8249119 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]